Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Primary relevance to vitamin D Vitamin D is a stated subject of this paper.

Vitamin D is a stated subject of this paper; the supporting source evidence is shown below.

Why this paper is included

Supporting source evidence:

This systematic review and meta-analysis of randomized clinical trials of vitamin D alone (11 randomized clinical trials with 34 243 participants) showed no significant association with risk of any fracture or of hip fracture.

Source: Abstract. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Review / evidence synthesis.

Review / evidence synthesis

Reviews existing research; the exact review methods need further assessment.

Meta-analysis reported · Blinding not applicable to this review · Research setting awaiting verification

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

Subsequently, we pooled the results of individual studies using inverse-variance weighted fixed-effects meta-analysis.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

Vitamin D and Calcium for the Prevention of Fracture

Review / evidence synthesis · JAMA Network Open · 2019

Original publication title

Vitamin D and Calcium for the Prevention of Fracture

Pang Yao; Derrick Bennett; Marion Mafham; Xu Lin; Zhengming Chen; Jane Armitage; Robert Clarke

Copyright 2019 Yao P et al. JAMA Network Open.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

Abstract: What objectives does the paper state?

To assess the risks of fracture associated with differences in concentrations of 25-hydroxyvitamin D (25[OH]D) in observational studies and the risks of fracture associated with supplementation with vitamin D alone or in combination with calcium in RCTs.

Source: Objective

Abstract: Question

What is the available evidence for the efficacy of vitamin D with or without calcium supplementation for reducing the risk of fracture?

Source: Question

Abstract: Meaning

In this study, neither intermittent nor daily dosing with standard doses of vitamin D alone was associated with reduced risk of fracture, but daily treatment with both vitamin D and calcium was a more promising strategy.

Source: Meaning

Abstract: Importance

Vitamin D and calcium supplements are recommended for the prevention of fracture, but previous randomized clinical trials (RCTs) have reported conflicting results, with uncertainty about optimal doses and regimens for supplementation and their overall effectiveness.

Source: Importance

Abstract: Data Sources

PubMed, EMBASE, Cochrane Library, and other RCT databases were searched from database inception until December 31, 2018. Searches were performed between July 2018 and December 2018.

Source: Data Sources

Abstract: Study Selection

Observational studies involving at least 200 fracture cases and RCTs enrolling at least 500 participants and reporting at least 10 incident fractures were included. Randomized clinical trials compared vitamin D or vitamin D and calcium with control.

Source: Study Selection

Abstract: Data Extraction and Synthesis

Two researchers independently extracted data according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines and assessed possible bias. Rate ratios (RRs) were estimated using fixed-effects meta-analysis. Data extraction and synthesis took place between July 2018 and June 2019.

Source: Data Extraction and Synthesis

Abstract: Main Outcomes and Measures

Any fracture and hip fracture.

Source: Main Outcomes and Measures

Abstract: Conclusions and Relevance

In this systematic review and meta-analysis, neither intermittent nor daily dosing with standard doses of vitamin D alone was associated with reduced risk of fracture, but daily supplementation with both vitamin D and calcium was a more promising strategy.

Source: Conclusions and Relevance

Abstract: Findings

This systematic review and meta-analysis of randomized clinical trials of vitamin D alone (11 randomized clinical trials with 34 243 participants) showed no significant association with risk of any fracture or of hip fracture. In contrast, daily supplementation with both vitamin D and calcium (6 randomized clinical trials with 49 282 participants) was associated with a 16% reduced risk of hip fracture.

Source: Findings
Authors’ abstract

Key Points

Question

What is the available evidence for the efficacy of vitamin D with or without calcium supplementation for reducing the risk of fracture?

Findings

This systematic review and meta-analysis of randomized clinical trials of vitamin D alone (11 randomized clinical trials with 34 243 participants) showed no significant association with risk of any fracture or of hip fracture. In contrast, daily supplementation with both vitamin D and calcium (6 randomized clinical trials with 49 282 participants) was associated with a 16% reduced risk of hip fracture.

Meaning

In this study, neither intermittent nor daily dosing with standard doses of vitamin D alone was associated with reduced risk of fracture, but daily treatment with both vitamin D and calcium was a more promising strategy.

This systematic review and meta-analysis assesses the risk of fracture associated with differences in concentrations of 25-hydroxyvitamin D (25[OH]D) in observational studies and the effects of supplementation with vitamin D alone or in combination with calcium on fracture in randomized clinical trials.

Importance

Vitamin D and calcium supplements are recommended for the prevention of fracture, but previous randomized clinical trials (RCTs) have reported conflicting results, with uncertainty about optimal doses and regimens for supplementation and their overall effectiveness.

Objective

To assess the risks of fracture associated with differences in concentrations of 25-hydroxyvitamin D (25[OH]D) in observational studies and the risks of fracture associated with supplementation with vitamin D alone or in combination with calcium in RCTs.

Data Sources

PubMed, EMBASE, Cochrane Library, and other RCT databases were searched from database inception until December 31, 2018. Searches were performed between July 2018 and December 2018.

Study Selection

Observational studies involving at least 200 fracture cases and RCTs enrolling at least 500 participants and reporting at least 10 incident fractures were included. Randomized clinical trials compared vitamin D or vitamin D and calcium with control.

Data Extraction and Synthesis

Two researchers independently extracted data according to the Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) guidelines and assessed possible bias. Rate ratios (RRs) were estimated using fixed-effects meta-analysis. Data extraction and synthesis took place between July 2018 and June 2019.

Main Outcomes and Measures

Any fracture and hip fracture.

Results

In a meta-analysis of 11 observational studies (39 141 participants, 6278 fractures, 2367 hip fractures), each increase of 10.0 ng/mL (ie, 25 nmol/L) in 25 (OH)D concentration was associated with an adjusted RR for any fracture of 0.93 (95% CI, 0.89-0.96) and an adjusted RR for hip fracture of 0.80 (95% CI, 0.75-0.86). A meta-analysis of 11 RCTs (34 243 participants, 2843 fractures, 740 hip fractures) of vitamin D supplementation alone (daily or intermittent dose of 400-30 000 IU, yielding a median difference in 25[OH]D concentration of 8.4 ng/mL) did not find a reduced risk of any fracture (RR, 1.06; 95% CI, 0.98-1.14) or hip fracture (RR, 1.14; 95% CI, 0.98-1.32), but these trials were constrained by infrequent intermittent dosing, low daily doses of vitamin D, or an inadequate number of participants.

In contrast, a meta-analysis of 6 RCTs (49 282 participants, 5449 fractures, 730 hip fractures) of combined supplementation with vitamin D (daily doses of 400-800 IU, yielding a median difference in 25[OH]D concentration of 9.2 ng/mL) and calcium (daily doses of 1000-1200 mg) found a 6% reduced risk of any fracture (RR, 0.94; 95% CI, 0.89-0.99) and a 16% reduced risk of hip fracture (RR, 0.84; 95% CI, 0.72-0.97).

Conclusions and Relevance

In this systematic review and meta-analysis, neither intermittent nor daily dosing with standard doses of vitamin D alone was associated with reduced risk of fracture, but daily supplementation with both vitamin D and calcium was a more promising strategy.

Publication and source details

Original title: Vitamin D and Calcium for the Prevention of Fracture

Pang Yao; Derrick Bennett; Marion Mafham; Xu Lin; Zhengming Chen; Jane Armitage; Robert Clarke

JAMA Network Open · 2019

Article Information

Accepted for Publication: October 27, 2019.

Published: December 20, 2019. doi:10.1001/jamanetworkopen.2019.17789

Open Access: This is an open access article distributed under the terms of the CC-BY License. © 2019 Yao P et al. JAMA Network Open.

Corresponding Author: Robert Clarke, FRCP, MD, Clinical Trial Service Unit and Epidemiological Studies Unit, Nuffield Department of Population Health, University of Oxford, Big Data Institute, Old Road Campus, Oxford OX3 7LF, United Kingdom (robert.clarke@ndph.ox.ac.uk).

Author Contributions: Drs Yao and Clarke had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. Dr Chen, Ms Armitage, and Dr Clarke are joint senior authors.

Concept and design: Yao, Chen, Armitage, Clarke.

Acquisition, analysis, or interpretation of data: Yao, Bennett, Mafham, Lin, Chen, Clarke.

Drafting of the manuscript: Yao, Clarke.

Critical revision of the manuscript for important intellectual content: Yao, Bennett, Mafham, Lin, Chen, Armitage.

Statistical analysis: Yao.

Administrative, technical, or material support: Yao, Bennett, Lin, Armitage.

Supervision: Bennett, Chen, Clarke.

Conflict of Interest Disclosures: Ms Armitage reported receiving grants from the UK Medical Research Council during the conduct of the study. No other disclosures were reported.

Funding/Support: Dr Yao was supported by a Sino-British Fellowship Trust scholarship.

Role of the Funder/Sponsor: The funder had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; preparation, review, or approval of the manuscript; and decision to submit the manuscript for publication.

Copyright 2019 Yao P et al. JAMA Network Open.https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.Sino-British Fellowship Trust

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-11T03:21:06.779128+00:00

DOI: 10.1001/jamanetworkopen.2019.17789 · PMC6991219